Loss of either isoform of PLD decreases phagocytosis. by Wahida H. Ali (286470)

BRCA1 silencing decreases cell viability. by Pei Chen (252989)

Mice exposed to neonatal hyperoxia have persistent RVH and decreased vessel density at 21d. by Marta Perez (526067)

Data Sheet 1_Reducing ocular Demodex using petroleum jelly may alleviate dry eye syndrome, blepharitis, facial dermatoses, ocular and respiratory allergies, and decrease associated... by Diana E. Senior-Fletcher (22090340)

“…Mean yearly issues of anti-allergy and antimicrobial medicines reduced from 15.6 (range 8–25) to 1.8 (range 0–4), representing an 88.5% decrease for Volunteer 1 and from 5.8 (range 3–9) and 14.2 issues (range 9–24) to zero for both Volunteer 2 and Volunteer 13 respectively, representing 100% reductions in prescribing. …”

Decreased Th2 response in B7RP-1^+/− mice. by Bryan S. Clay (355764)

Decreased focus score in early treated mice. by Nienke Roescher (159484)

miR-100 decreases tumor size. by Bahauddeen M. Alrfaei (484859)

Maximum IFN concentrations are decreased in severe patients. by Sonia T. Gazeau (21512764)

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

Subjects:

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

Subjects:

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

Subjects:

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

Subjects:

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

Subjects:

Vi expression decreases antibody and complement binding to <i>Salmonella</i> in the absence of specific antibodies. by Peter J. Hart (503558)

PG treatment decreases HCC cell survival. by Po-Li Wei (292225)

The Intracellular level of FLASH decreases during apoptosis. by Song Chen (69646)

Madrasin decreases transcription of protein-coding genes. by Michael Tellier (8284752)

Sepsis decreases the frequencies of CD4 T cells. by Mian Zhou (339595)

Purine nucleotides are decreased in long-term hypoxia. by Emily B. Cohen (9106088)

Decreased H4R expression in GCs. by Chao Zhang (51048)